Microbot Medical Inc (MBOT) concluded trading on Wednesday at a closing price of $1.79, with 4.65 million shares of worth about $8.32 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 63.47% during that period and on January 15, 2025 the price saw a gain of about 16.23%. Currently the company’s common shares owned by public are about 28.03M shares, out of which, 22.98M shares are available for trading.
Stock saw a price change of -36.75% in past 5 days and over the past one month there was a price change of 79.13%. Year-to-date (YTD), MBOT shares are showing a performance of 59.82% which increased to 31.62% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.82 but also hit the highest price of $3.38 during that period. The average intraday trading volume for Microbot Medical Inc shares is 2.24 million. The stock is currently trading 22.74% above its 20-day simple moving average (SMA20), while that difference is up 53.46% for SMA50 and it goes to 72.44% higher than SMA200.
Microbot Medical Inc (NASDAQ: MBOT) currently have 28.03M outstanding shares and institutions hold larger chunk of about 8.57% of that.
The stock has a current market capitalization of $50.18M and its 3Y-monthly beta is at 1.41. It has posted earnings per share of -$0.80 in the same period. It has Quick Ratio of 3.64 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MBOT, volatility over the week remained 25.89% while standing at 18.22% over the month.
Analysts are in expectations that Microbot Medical Inc (MBOT) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is 0 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.26 in the same quarter a year ago.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on January 13, 2020 offering a Buy rating for the stock and assigned a target price range of between $12 and $26 to it. Coverage by H.C. Wainwright stated Microbot Medical Inc (MBOT) stock as a Buy in their note to investors on December 24, 2019, suggesting a price target of $12 for the stock.
